StockNews.AI
PROF
StockNews.AI
146 days

Wolf Haldenstein Adler Freeman & Herz LLP is investigating Profound Medical Corp. for potential violations of securities laws

1. Investors of PROF face a potential securities fraud investigation. 2. An error overstated PROF's revenue by $472,000 in Q1 2024. 3. Quarterly reports for 2024 are now deemed unreliable for investors. 4. PROF shares dropped by 5.9% following the revenue overstatement news.

3m saved
Insight
Article

FAQ

Why Bearish?

The revenue error and investigation into potential fraud can significantly harm investor confidence. Historical cases often saw share prices tumble after such revelations, like the Dole Food Company's reported misstatements in 2014, which led to a prolonged decline in stock value.

How important is it?

The ongoing investigation and implications of securities fraud directly affect PROF's operational viability and investor trust, which are crucial for its market performance.

Why Short Term?

Immediate investor reactions to the fraud investigation may lead to short-term volatility. If the investigation results in negative findings, longer-term impacts could follow despite possible rebounds.

PLEASE CLICK HERE TO PROVIDE YOUR CONTACT INFORMATION NEW YORK, March 26, 2025 (GLOBE NEWSWIRE) -- Wolf Haldenstein Adler Freeman & Herz LLP ("Wolf Haldenstein"), a preeminent national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Profound Medical Corp. (NASDAQ: PROF) (“Profound” or the “Company”). The investigation concerns whether and certain of its officers and/or directors have engaged in securities fraud.    PLEASE CLICK HERE TO PROVIDE YOUR CONTACT INFORMATION Profound disclosed in an SEC filing on March 7, 2025, that "the Company identified an error which overstated revenue by $472,000 in the first quarter of 2024." The Company admitted that its quarterly reports for the first three quarters of 2024 could no longer be relied upon by investors. Based on this news, shares of Profound fell by 5.9% on the same day.   Wolf Haldenstein has experience in the prosecution of securities class actions and derivative litigation in state and federal trial and appellate courts across the country. The firm has attorneys in various practice areas, and offices in New York, Chicago, Nashville and San Diego. The reputation and expertise of this firm in shareholder and other class litigation has been repeatedly lauded by the courts, which have appointed it to major positions in complex securities, multi-district and consolidated litigation. If you wish to discuss this investigation or have any questions regarding your rights and interests, please immediately contact Wolf Haldenstein by telephone at (800) 575-0735 or via e-mail at classmember@whafh.com. Contact: Wolf Haldenstein Adler Freeman & Herz LLPGregory Stone, Director of Case and Financial AnalysisEmail: gstone@whafh.com or classmember@whafh.comTel: (800) 575-0735 or (212) 545-4774 This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.

Related News